Search Results

There are 6666176 results for: content related to: The effects of cisapride on plasma L -dopa levels and clinical response in Parkinson's disease

  1. Parkinsonism, biochemical and therapeutic aspects

    Acta Neurologica Scandinavica

    Volume 48, Issue s51, November 1972, Pages: 9–150,

    Article first published online : 8 DEC 2008, DOI: 10.1111/j.1600-0404.1972.tb06744.x

  2. You have free access to this content
    Unpredictable Rotational Responses to L-dopa in the Rat Model of Parkinson’s Disease: the Role of L-dopa Pharmacokinetics and Striatal Dopamine Depletion

    Basic & Clinical Pharmacology & Toxicology

    Volume 110, Issue 2, February 2012, Pages: 162–170, Tiina M. Kääriäinen, Mikko Käenmäki, Markus M. Forsberg, Niko Oinas, Anne Tammimäki and Pekka T. Männistö

    Article first published online : 13 SEP 2011, DOI: 10.1111/j.1742-7843.2011.00782.x

  3. Poster session 2: Parkinson's Disease

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S65–S114,

    Article first published online : 21 OCT 2002, DOI: 10.1002/mds.10350

  4. You have free access to this content
    Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats

    Neurogastroenterology & Motility

    Volume 24, Issue 5, May 2012, Pages: e235–e245, L. Wang, N. P. Murphy, A. Stengel, M. Goebel-Stengel, D. H. St Pierre, N. T. Maidment and Y. Taché

    Article first published online : 23 MAR 2012, DOI: 10.1111/j.1365-2982.2012.01904.x

  5. You have free access to this content
    l-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells

    Journal of Neurochemistry

    Volume 78, Issue 3, August 2001, Pages: 535–545, E. Rodríguez-Martín, S. Canals, M. J. Casarejos, S. de Bernardo, A. Handler and M. A. Mena

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00440.x

  6. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Article first published online : 12 JUN 2015, DOI: 10.1002/mds.26295

  8. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Article first published online : 28 MAY 2008, DOI: 10.1002/mds.22133

  9. Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease

    European Journal of Neuroscience

    Volume 20, Issue 5, September 2004, Pages: 1255–1266, S. Robelet, C. Melon, B. Guillet, P. Salin and L. Kerkerian-Le Goff

    Article first published online : 18 AUG 2004, DOI: 10.1111/j.1460-9568.2004.03591.x

  10. Chronic administration does not alter the accumulation of L-dopa into muscle

    Movement Disorders

    Volume 9, Issue 2, 1994, Pages: 167–172, S. Rose, Dr. P. Jenner and C. D. Marsden

    Article first published online : 12 OCT 2004, DOI: 10.1002/mds.870090207

  11. You have free access to this content
    Levodopa: Effect on cell death and the natural history of Parkinson's disease

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 37–44, C. Warren Olanow

    Article first published online : 11 DEC 2014, DOI: 10.1002/mds.26119

  12. Intravenous boluses and continuous infusions of L-DOPA methyl ester in fluctuating patients with Parkinson's disease

    Movement Disorders

    Volume 7, Issue 3, 1992, Pages: 249–256, Dr. F. Stocchi, S. Ruggieri, A. Carta, J. Ryatt, N. Quinn, P. Jenner, C. D. Marsden and A. Agnoli

    Article first published online : 12 OCT 2004, DOI: 10.1002/mds.870070311

  13. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease

    Journal of Pineal Research

    Volume 40, Issue 3, April 2006, Pages: 204–213, Gaia Rocchitta, Rossana Migheli, Giovanni Esposito, Bianca Marchetti, Maria S. Desole, Egidio Miele and Pier Andrea Serra

    Article first published online : 5 DEC 2005, DOI: 10.1111/j.1600-079X.2005.00299.x

  14. You have free access to this content
    L-DOPA Does Not Enhance Hydroxyl Radical Formation in the Nigrostriatal Dopamine System of Rats with a Unilateral 6-Hydroxydopamine Lesion

    Journal of Neurochemistry

    Volume 74, Issue 3, March 2000, Pages: 1229–1240, Dianne M. Camp, David A. Loeffler and Pater A. LeWitt

    Article first published online : 19 MAR 2003, DOI: 10.1046/j.1471-4159.2000.741229.x

  15. You have free access to this content
    Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 19–36, Andrew J. Lees, Eduardo Tolosa and C. Warren Olanow

    Article first published online : 8 DEC 2014, DOI: 10.1002/mds.26120

  16. You have free access to this content
    The medical treatment of Parkinson disease from James Parkinson to George Cotzias

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 4–18, Stanley Fahn

    Article first published online : 9 DEC 2014, DOI: 10.1002/mds.26102

  17. You have free access to this content
    Improving l-dopa therapy: The development of enzyme inhibitors

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 103–113, Oscar S. Gershanik

    Article first published online : 21 OCT 2014, DOI: 10.1002/mds.26050

  18. You have free access to this content
    Serotonergic modulation of receptor occupancy in rats treated with l-DOPA after unilateral 6-OHDA lesioning

    Journal of Neurochemistry

    Volume 120, Issue 5, March 2012, Pages: 806–817, Adjmal Nahimi, Mette Høltzermann, Anne M. Landau, Mette Simonsen, Steen Jakobsen, Aage Kristian Olsen Alstrup, Kim Vang, Arne Møller, Gregers Wegener, Albert Gjedde and Doris J. Doudet

    Article first published online : 23 JAN 2012, DOI: 10.1111/j.1471-4159.2011.07598.x

  19. You have free access to this content
    On the mechanism of l-DOPA-induced postural hypotension in the cat

    British Journal of Pharmacology

    Volume 47, Issue 3, March 1973, Pages: 437–451, K. M. DHASMANA and B. A. SPILKER

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1973.tb08175.x

  20. You have free access to this content
    Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease

    British Journal of Pharmacology

    Volume 130, Issue 4, June 2000, Pages: 937–945, Pier Andrea Serra, Giovanni Esposito, Paolo Enrico, Maria A Mura, Rossana Migheli, M Rosaria Delogu, Maddalena Miele, Maria S Desole, Giuseppe Grella and Egidio Miele

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703379